Question 1

What are the potential benefits of participating in this trial for my condition?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Cemiplimab-rwlc for Unresectable Locally Recurrent and/or Metastatic CSCC clinical trial (NCT04242173). Contact the study team or your healthcare provider for specific answers.

Question 2

How does Cemiplimab-rwlc compare to other treatments I might consider?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Cemiplimab-rwlc for Unresectable Locally Recurrent and/or Metastatic CSCC clinical trial (NCT04242173). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I expect from this treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Cemiplimab-rwlc for Unresectable Locally Recurrent and/or Metastatic CSCC clinical trial (NCT04242173). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for visits and treatments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Cemiplimab-rwlc for Unresectable Locally Recurrent and/or Metastatic CSCC clinical trial (NCT04242173). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects or complications during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Cemiplimab-rwlc for Unresectable Locally Recurrent and/or Metastatic CSCC clinical trial (NCT04242173). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any costs associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Cemiplimab-rwlc for Unresectable Locally Recurrent and/or Metastatic CSCC clinical trial (NCT04242173). Contact the study team or your healthcare provider for specific answers.

What this study is about